Menu Back toPoster-Presentations-and-Networking-Reception-8410998

Global Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest global requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

Poster Presentations and Networking Reception

Session Chair(s)

Session Chair Totally Invited

Session Chair Totally Invited

  • DIA, United States
Poster Presentations and Networking Reception


Michelle  Hellstern, BSN

Redaction Impact and Efficiencies Assessed for Optimal Transparency Preparation for the EU Clinical Trial Regulation 536/2014

Michelle Hellstern, BSN

  • Manager, Clinical Trial Disclosure & Transparency
  • CSL Behring, United States
Raina  Agarwal, MPharm

Assessment of Anonymization Methods, Processes, and Challenges for Clinical Information Submissions to Health Canada

Raina Agarwal, MPharm

  • Senior Manager
  • Kinapse Ltd, A Syneos Health Company, United States
Cathal  Gallagher

Do You Know Your Risk?

Cathal Gallagher

  • TAG Member & Transparency Lead
  • d-wise, United Kingdom
Lucy  Mosquera

Experiences Generating Synthetic Clinical Trial Data

Lucy Mosquera

  • Lead Statistician
  • Replica Analytics, Canada
Veera  Thota

Automating Data Anonymization Procedures with Software

Veera Thota

  • MMS Holdings, United States
Pooja  Phogat, PhD

Actionable Insights for Plain Language Summary Implementation

Pooja Phogat, PhD

  • VP, Head of Development Operations
  • Kinapse, A Syneos Health Company, India
Nirpal  Virdee, MSc

The Future of Transparency: How Global Regulatory Authorities May Expect Patient and HCP Engagement During the Drug Approval Process

Nirpal Virdee, MSc

  • Head, Transparency & Disclosure
  • Certara, United Kingdom